PERIOMED ORIGINAL 037 OCTOBER 2026

ORAL · IMMUNE · SYSTEMIC

The interplay between oral and systemic inflammation.

From biological links to clinical relevance.

AUTHOR · ORAL & PERIODONTAL SCIENCESNadja Celine FabbriItaly

AUTHOR · MEDICAL SCIENCESSofia Cominoli, MDItaly

AUTHOR · PUBLIC HEALTH & EDUCATIONAbdulrahman AlghamdiPhD Candidate · Saudi Arabia

THE CENTRAL IDEA

Inflammation may begin locally.
Its biological conversation may not end there.

Oral and systemic health are increasingly understood as interconnected rather than separate domains. Periodontitis offers a particularly useful model: a dysbiotic microbial community and a sustained, dysregulated host response coexist at a highly vascular interface.

The effects of this inflammatory environment may extend beyond the oral cavity through transient microbial dissemination, circulating mediators, oxidative stress and altered immune responses. The strength of evidence is not equal for every condition, and biological plausibility must not be confused with demonstrated causality.

ONE LOCAL PROCESS · MULTIPLE ROUTES

How periodontal inflammation can enter a wider biological system.

Dysbiosis

A microbial community and host response lose their equilibrium.

→

Barrier disruption

Inflamed, vascular periodontal tissues increase contact with the circulation.

→

Circulating signals

Microbial products and inflammatory mediators travel beyond the mouth.

→

Systemic response

Immune, metabolic and vascular pathways may be influenced.

A credible biological framework is not proof of causality. The contribution of each pathway may differ substantially between diseases and between individuals.

Several mechanisms may overlap rather than operate in isolation.

Periodontal tissue destruction results from an abnormal host inflammatory response to a dysbiotic microbial community. Disruption of the epithelial barrier can permit episodes of transient bacteraemia, allowing microorganisms, virulence factors and microbial components to circulate beyond the oral cavity. At distant sites, these signals may stimulate innate immune pathways. [1] [2] [3]

A related mechanism involves inflammatory signalling generated by the host. Periodontal inflammation is associated with mediators including IL-1β, IL-6 and TNF-α. Together with responses to circulating microbial products, they may contribute to hepatic acute-phase responses and wider systemic inflammatory activity. Higher circulating C-reactive protein has been reported in people with periodontitis. [3] [4]

These observations provide a biologically coherent explanation for interaction between oral inflammation and the wider organism. They do not establish how much each route contributes to a specific systemic disease.

THE EVIDENCE IS NOT ONE-SIZE-FITS-ALL

Different conditions. Different levels of certainty.

Diabetes mellitus

The clearest bidirectional model.

Poor glycaemic control is associated with more severe periodontal disease, while periodontal inflammation may contribute to systemic inflammatory activity and impaired metabolic control. Periodontal treatment has been associated with modest short-term reductions in HbA1c, although the durability and long-term clinical meaning remain uncertain. [5] [6]

Cardiovascular disease

A strong association; causality remains unresolved.

Epidemiological consistency and plausible microbial, inflammatory, oxidative and endothelial pathways strengthen the case for a biological relationship. Current evidence does not demonstrate that periodontal treatment prevents major cardiovascular events. [7] [8]

Rheumatoid arthritis

Shared inflammatory biology under investigation.

Persistent inflammation, altered immune regulation and tissue damage are common to both diseases. Specific periodontal microorganisms may influence citrullination and immune tolerance, but epidemiological and interventional evidence is less definitive. [9]

Other conditions

Each association must stand on its own evidence.

Research has also examined respiratory disease and adverse pregnancy outcomes. These relationships differ in strength, direction and possible causal interpretation and should not be collapsed into one universal pathway. [10] [11]

FROM BIOLOGY TO CARE

Integration without overclaiming.

Oral-health assessment can be part of broader prevention and chronic-disease management—while systemic claims remain tied to outcomes that have actually been demonstrated.

Periodontal treatment reliably reduces local inflammatory disease. Selected studies also report changes in glycaemic, inflammatory and vascular surrogate markers. A change in a biomarker, however, is not equivalent to prevention of a clinical event. [5] [7] [8]

Closer communication between dental and medical professionals may be particularly useful for people living with both diabetes and periodontitis. At population level, a common risk-factor approach can address tobacco use, unhealthy dietary patterns, metabolic dysfunction and socioeconomic disadvantage across oral and general health. [12] [13]

WHAT THE NEXT STUDIES MUST ANSWER

The question is no longer whether diseases occur together.

Does periodontal inflammation make a causal, clinically meaningful and modifiable contribution to systemic disease?

Causality

Move beyond cross-sectional associations and address shared determinants rigorously.

Clinical outcomes

Look beyond short-term surrogate biomarkers toward sustained patient outcomes.

Who is most susceptible?

Combine clinical assessment with immune, microbiome and molecular profiling.

Integrated research

Bring periodontal and medical disciplines together without replacing established clinical methods.

Precision periodontology may eventually refine risk stratification, but molecular tools should complement—not replace—validated clinical assessment. [14]

THE PERSPECTIVE

The mouth is not an isolated inflammatory compartment.

Microbial dissemination, inflammatory signalling and altered immune responses provide credible mechanisms through which periodontal disease could interact with systemic pathways. Yet the evidence is not uniform across conditions. The next phase of research should focus less on accumulating associations and more on determining which relationships are causal, clinically important and modifiable.

Connected biology calls for connected questions—and for clinical collaboration that remains as careful as the evidence itself.

REFERENCES